Sort
21,453 grants matching “tuberculosis”
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$725,877David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Development of a New Diamine (SQ109) for the Treatment of C. difficile Infection
$725,821Marina N Protopopova · Sequella, Inc. · R01 · FY2013 · AI
Structural characterization of MCE transport systems from Mycobacterium tuberculosis
$725,790Gira Bhabha · Johns Hopkins University · R01 · FY2025 · AI
When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective
$725,525Anna Bershteyn · New York University School Of Medicine · R01 · FY2023 · MH
TUBERCULOSIS ELIMINATION AND LABORATORY
$725,448Rhonda D Smith · Baltimore City Health Department · U52 · FY2006 · PS
Administrative Core
$725,396David Louis Horn · Boston Medical Center · U19 · FY2015 · AI
Development of a New Diamine (SQ109) for the Treatment of C. difficile Infection
$725,317Marina N Protopopova · Sequella, Inc. · R01 · FY2014 · AI
Novel Biomarkers to Shorten TB Treatment
$725,266David Alland · Rbhs-New Jersey Medical School · R01 · FY2018 · AI
Macaque Models of AIDS-Related Tuberculosis and T Cell
$725,199University Of Illinois At Chicago · R01 · FY2004 · HL
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure
$724,871Christina Louise Lancioni · Oregon Health & Science University · R01 · FY2025 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$724,867William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2014 · AI
Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies
$724,795Igor Kramnik · Boston University Medical Campus · R01 · FY2022 · HL
Identifying Optimal Treatment Strategies for Tuberculosis Treatment
$724,769Radojka Savic · University Of California, San Francisco · R01 · FY2023 · AI
Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.
$724,699Kathleen Powis · Massachusetts General Hospital · R01 · FY2019 · AI
Sensitive Detection of Bacterial Contamination in Platelets
$724,627Season S-S Wong · Lynntech, Inc. · R44 · FY2007 · HL
Ultrasensitive detection of Mycobacterium tuberculosis infection
$724,592Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R01 · FY2025 · AI
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics
$724,479Michael R Wilson · University Of California, San Francisco · R01 · FY2019 · AI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
$724,208Diane V Havlir · University Of California, San Francisco · R01 · FY2017 · AI
HIV - Emergence of Drug Resistance
$724,023Sally Margaret Blower · University Of California Los Angeles · R01 · FY2009 · AI
Strengthening evidence on optimal multidrug-resistant tuberculosis treatment regimens through improved epidemiologic methods
$723,588Molly Forrest Franke · Harvard Medical School · R01 · FY2023 · AI
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting
$723,336James C M Brust · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)
$723,314Karen R Jacobson · Boston Medical Center · R01 · FY2019 · AI
Advanced Genotypic and Phenotypic monitoring of Drug Resistant TB to Improve TB Treatment Outcomes
$723,278Michelle H Larsen · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Emergence of bedaquiline, pretomanid and linezolid resistance after implementation of new drug-resistant tuberculosis regimens in South Africa
$722,947Barun Mathema · Columbia University Health Sciences · R01 · FY2024 · AI
IMPACT OF TUBERCULOSIS OF HIV INFECTION IN UGANDA
$722,886Case Western Reserve University · R01 · FY2003 · AI